Loading…
Jagsonpal Pharmaceuticals (JAGSNPHARM)₹217.42+0.01%Pharmaceuticals
At the end of the Sep 2026 quarter, Jagsonpal Pharmaceuticals' shareholders were: promoters 68.83%, FIIs 2.14%, DIIs 1.63%, public 27.40%. Promoter holding is down 0.24 percentage points from 69.07% a quarter earlier. FII holding is up 0.01 percentage points from 2.13% a year earlier. 0.00% of promoter shares were pledged. It had 26,525 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 68.49% | 68.10% | 68.05% | 67.99% | 67.83% | 67.78% | 67.66% | 67.55% | 67.40% | 67.90% | 69.07% | 68.83% |
| FIIs | 0.53% | 0.73% | 1.11% | 2.31% | 2.11% | 2.11% | 2.18% | 2.13% | 2.13% | 2.45% | 2.31% | 2.14% |
| DIIs | 0.81% | 0.83% | 0.83% | 0.11% | 0.00% | 0.00% | 0.05% | 0.08% | 0.15% | 0.22% | 0.62% | 1.63% |
| Public | 30.16% | 30.33% | 30.01% | 29.59% | 30.06% | 30.11% | 30.11% | 30.24% | 30.32% | 29.43% | 28.00% | 27.40% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 15,778 | 16,275 | 15,741 | 15,626 | 18,463 | 21,075 | 22,889 | 24,642 | 24,884 | 26,252 | 24,170 | 26,525 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Aresko Progressive Private Limited (Trustee of Aresko Progressive Trust, in the capacity of representative) partner of J&P Investments Partnership) | Promoter | 20.24% | −0.07 |
| INFINITY CAPITAL (Formerly Infinity Holdings Sidecar1) | Promoter | 17.95% | −0.06 |
| Infinity Holdings | Promoter | 16.67% | −0.06 |
| Infinity Portfolio Holdings | Promoter | 8.71% | −0.03 |
| Rajpal Singh Kochhar | Promoter | 4.60% | −0.01 |
| Manish Gupta | Public | 3.16% | +0.10 |
| Authum Investment And Infrastructure Limited | Public | 1.48% | 0.00 |
| Investor Education And Protection Fund Authority Ministry Of Corporate Affairs | Public | 1.48% | 0.00 |
| Lincoln P Coelho | Public | 1.16% | −0.01 |
| Prithipal Singh Kochhar | Promoter | 0.41% | 0.00 |
| Inderpal Singh Kochhar | Promoter | 0.28% | 0.00 |
| Sanjiv Kumar Dudeja | Public | Exited | — |
| Aresko Progressive Pvt. Ltd | Promoter | 0.00% | 0.00 |
| Infinity Consumer Holdings | Promoter | 0.00% | 0.00 |
Promoters held 68.83% of Jagsonpal Pharmaceuticals at the end of the Sep 2026 quarter, up 1.28 percentage points from 67.55% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 2.14% (down 0.17 percentage points from 2.31% a quarter earlier) and domestic institutions (DIIs) held 1.63% (up 1.01 percentage points from 0.62% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Jagsonpal Pharmaceuticals had 26,525 shareholders at the end of the Sep 2026 quarter, against 24,642 a year earlier.
Manish Gupta (Public) held 3.16% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.